Log in

OTCMKTS:ECTE - Echo Therapeutics Stock Price, Forecast & News

$0.0049
0.00 (0.00 %)
(As of 01/27/2020 08:05 AM ET)
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range
$0.00
MA: $0.01
$0.01
52-Week Range
$0.00
Now: $0.00
$0.04
Volume10,662 shs
Average Volume13,351 shs
Market Capitalization$65,170.00
P/E RatioN/A
Dividend YieldN/A
Beta9.71
Echo Therapeutics, Inc engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ECTE
Previous SymbolNASDAQ:ECTE
CUSIPN/A
Phone732-549-0128

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees19
Market Cap$65,170.00
Next Earnings DateN/A
OptionableNot Optionable

Receive ECTE News and Ratings via Email

Sign-up to receive the latest news and ratings for ECTE and its competitors with MarketBeat's FREE daily newsletter.


Echo Therapeutics (OTCMKTS:ECTE) Frequently Asked Questions

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics Inc (OTCMKTS:ECTE) announced its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same quarter in the previous year, the business earned ($0.97) earnings per share. View Echo Therapeutics' Earnings History.

Has Echo Therapeutics been receiving favorable news coverage?

News articles about ECTE stock have been trending somewhat negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Echo Therapeutics earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Echo Therapeutics.

Who are some of Echo Therapeutics' key competitors?

Some companies that are related to Echo Therapeutics include Magna-Lab (MAGAA), Newcardio (NWCI), 21st North (ULGX), IMRIS (IMRSQ) and SpectraScience (SCIE).

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include DexCom (DXCM), NovaBay Pharmaceuticals (NBY), Acer Therapeutics (ACER), Biocept (BIOC), Rexahn Pharmaceuticals (REXN), CytRx (CYTR), InterCloud Systems (ICLD), SLS International (SLS), Athersys (ATHX) and Aware (AWRE).

Who are Echo Therapeutics' key executives?

Echo Therapeutics' management team includes the folowing people:
  • Mr. Alan W. Schoenbart CPA, Chief Exec. Officer, Chief Financial Officer and Director (Age 60)

How do I buy shares of Echo Therapeutics?

Shares of ECTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Echo Therapeutics' stock price today?

One share of ECTE stock can currently be purchased for approximately $0.00.

How big of a company is Echo Therapeutics?

Echo Therapeutics has a market capitalization of $65,170.00. Echo Therapeutics employs 19 workers across the globe.View Additional Information About Echo Therapeutics.

What is Echo Therapeutics' official website?

The official website for Echo Therapeutics is http://www.echotx.com/.

How can I contact Echo Therapeutics?

Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The medical device company can be reached via phone at 732-549-0128 or via email at [email protected]


MarketBeat Community Rating for Echo Therapeutics (OTCMKTS ECTE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  164 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  303
MarketBeat's community ratings are surveys of what our community members think about Echo Therapeutics and other stocks. Vote "Outperform" if you believe ECTE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ECTE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel